Literature DB >> 7865881

Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.

W F Denetclaw1, F W Hopf, G A Cox, J S Chamberlain, R A Steinhardt.   

Abstract

A lack of dystrophin results in muscle degeneration in Duchenne muscular dystrophy. Dystrophin-deficient human and mouse muscle cells have higher resting levels of intracellular free calcium ([Ca2+]i) and show a related increase in single-channel open probabilities of calcium leak channels. Elevated [Ca2+]i results in high levels of calcium-dependent proteolysis, which in turn increases calcium leak channel activity. This process could initiate muscle degeneration by further increasing [Ca2+]i and proteolysis in a positive feedback loop. Here, we tested the direct effect of restoration of dystrophin on [Ca2+]i and channel activity in primary myotubes from mdx mice made transgenic for full-length dystrophin. Transgenic mdx mice have been previously shown to have normal dystrophin localization and no muscle degeneration. Fura-2 calcium measurements and single-channel patch recordings showed that resting [Ca2+]i levels and open probabilities of calcium leak channels of transgenic mdx myotubes were similar to normal levels and significantly lower than mdx littermate controls (mdx) that lack dystrophin. Thus, restoration of normal calcium regulation in transgenic mdx mice may underlie the resulting absence of degeneration.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7865881      PMCID: PMC301138          DOI: 10.1091/mbc.5.10.1159

Source DB:  PubMed          Journal:  Mol Biol Cell        ISSN: 1059-1524            Impact factor:   4.138


  46 in total

1.  Intracellular ion activities and membrane transport in parietal cells measured with fluorescent dyes.

Authors:  P A Negulescu; T E Machen
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

2.  Effects of calcium on protein turnover of incubated muscles from mdx mice.

Authors:  P A MacLennan; A McArdle; R H Edwards
Journal:  Am J Physiol       Date:  1991-04

Review 3.  Non-ligand-activated chloride channels of skeletal muscle and epithelia.

Authors:  P C Vaughan; A S French
Journal:  Prog Biophys Mol Biol       Date:  1989       Impact factor: 3.667

Review 4.  Dystrophin abnormalities in Duchenne/Becker muscular dystrophy.

Authors:  E P Hoffman; L M Kunkel
Journal:  Neuron       Date:  1989-01       Impact factor: 17.173

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin.

Authors:  P Y Fong; P R Turner; W F Denetclaw; R A Steinhardt
Journal:  Science       Date:  1990-11-02       Impact factor: 47.728

7.  Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle.

Authors:  J M Ervasti; K Ohlendieck; S D Kahl; M G Gaver; K P Campbell
Journal:  Nature       Date:  1990-05-24       Impact factor: 49.962

8.  Fiber regeneration is not persistent in dystrophic (MDX) mouse skeletal muscle.

Authors:  J X DiMario; A Uzman; R C Strohman
Journal:  Dev Biol       Date:  1991-11       Impact factor: 3.582

9.  Total ion content of skeletal and cardiac muscle in the mdx mouse dystrophy: Ca2+ is elevated at all ages.

Authors:  J F Dunn; G K Radda
Journal:  J Neurol Sci       Date:  1991-06       Impact factor: 3.181

10.  Discrimination of Ca(2+)-ATPase activity of the sarcoplasmic reticulum from actomyosin-type ATPase activity of myofibrils in skinned mammalian skeletal muscle fibres: distinct effects of cyclopiazonic acid on the two ATPase activities.

Authors:  N Kurebayashi; Y Ogawa
Journal:  J Muscle Res Cell Motil       Date:  1991-08       Impact factor: 2.698

View more
  9 in total

1.  Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice.

Authors:  C Collet; B Allard; Y Tourneur; V Jacquemond
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

Review 2.  Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse.

Authors:  J M Gillis
Journal:  J Muscle Res Cell Motil       Date:  1999-10       Impact factor: 2.698

Review 3.  New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD.

Authors:  Bruno Constantin; Stéphane Sebille; Christian Cognard
Journal:  J Muscle Res Cell Motil       Date:  2006-08-04       Impact factor: 2.698

Review 4.  The dystrophin superfamily: variability and complexity.

Authors:  E Fabbrizio; F Pons; A Robert; G Hugon; A Bonet-Kerrache; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  1994-12       Impact factor: 2.698

5.  Regulation of cytosolic calcium in skeletal muscle cells of the mdx mouse under conditions of stress.

Authors:  W J Leijendekker; A C Passaquin; L Metzinger; U T Rüegg
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

6.  Mdx myotubes have normal excitability but show reduced contraction-relaxation dynamics.

Authors:  V Nicolas-Metral; E Raddatz; P Kucera; U T Ruegg
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

7.  Mini-dystrophin restores L-type calcium currents in skeletal muscle of transgenic mdx mice.

Authors:  O Friedrich; M Both; J M Gillis; J S Chamberlain; R H A Fink
Journal:  J Physiol       Date:  2003-10-31       Impact factor: 5.182

Review 8.  Wasting mechanisms in muscular dystrophy.

Authors:  Jonghyun Shin; Marjan M Tajrishi; Yuji Ogura; Ashok Kumar
Journal:  Int J Biochem Cell Biol       Date:  2013-05-11       Impact factor: 5.085

9.  Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.

Authors:  D J Burkin; G Q Wallace; K J Nicol; D J Kaufman; S J Kaufman
Journal:  J Cell Biol       Date:  2001-03-19       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.